2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1053512343 MD
Verify on CMS →

ALINA KHAN-GHANY, MD

Endocrinology, Diabetes & Metabolism Physician in MIAMI GARDENS, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
327
Medicare Part D claims · 86 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
40%
generic claims · 60% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ALINA KHAN-GHANY, MD filed 327 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in MIAMI GARDENS, Florida, prescribing 40% generic.

327
Part D claims, 2023
40%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALINA KHAN-GHANY, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

327 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ALINA KHAN-GHANY, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALINA KHAN-GHANY, MD?

Quality data not reported

NPI registry status

Active

Issued 05/31/2007

NPI 1053512343

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

327 88% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Florida

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers

Florida providers

Endocrinology, Diabetes & Metabolism Physician share within Florida

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALINA KHAN-GHANY, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 20801 NW 2ND AVENUE, MIAMI GARDENS, FL, 33169, with a listed phone of (305) 653-1770. NPI 1053512343 was issued on 05/31/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHAN-GHANY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 327 prescription claims written by this provider, covering 86 Medicare beneficiaries and totaling roughly $136K in drug spend, split 60% brand-name and 40% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

20801 NW 2ND AVENUE
MIAMI GARDENS, FL 33169

Provider Details

NPI 1053512343
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 05/31/2007

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ALINA KHAN-GHANY, MD. To verify ALINA KHAN-GHANY, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ALINA KHAN-GHANY, MD — brand share 60.0%
Specialty average (est.)

60% brand-name claims vs 40% generic, on 327 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

327
Total Claims
$136K
Total Drug Cost
86
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
754
Total Day Supply
22,364
Brand vs Generic
60% brand / 40% generic
Brand Drug Cost
$128K
Generic Drug Cost
$1K

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
2.66
Gender Split
79% female / 21% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALINA KHAN-GHANY, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Methimazole
23
Ozempic
Semaglutide
23
Novolin 70-30
Insulin Nph Hum/Reg Insulin Hm
22
Synthroid
Levothyroxine Sodium
20
Novolin 70-30 Flexpen
Insulin Nph Hum/Reg Insulin Hm
19
Novolog Flexpen
Insulin Aspart
18
Metformin Hcl
11
Lantus Solostar
"Insulin Glargine
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ALINA KHAN-GHANY, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ALINA KHAN-GHANY, MD's 327 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as KHAN-GHANY.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALINA KHAN-GHANY, MD's specialty?
ALINA KHAN-GHANY, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MIAMI GARDENS, Florida. Credentials: MD.
How much does ALINA KHAN-GHANY, MD prescribe under Medicare Part D?
In 2023, ALINA KHAN-GHANY, MD wrote 327 Medicare Part D claims totaling $136K in drug costs for 86 beneficiaries.
Where is ALINA KHAN-GHANY, MD located?
ALINA KHAN-GHANY, MD is located at 20801 NW 2ND AVENUE, MIAMI GARDENS, FL, 33169. Phone: (305) 653-1770.
What is ALINA KHAN-GHANY, MD's NPI number?
ALINA KHAN-GHANY, MD's National Provider Identifier (NPI) is 1053512343, issued on 05/31/2007.
Does ALINA KHAN-GHANY, MD prescribe more brand-name or generic drugs?
ALINA KHAN-GHANY, MD's prescribing is 60% brand-name and 40% generic drugs by claim count, with $128K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ALINA KHAN-GHANY, MD prescribe most often?
Based on 2023 Medicare Part D data, ALINA KHAN-GHANY, MD's most frequently prescribed drugs include Methimazole, Ozempic, Novolin 70-30. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALINA KHAN-GHANY, MD accept Medicare?
ALINA KHAN-GHANY, MD appears in CMS Medicare data with 327 Part D claims and 86 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALINA KHAN-GHANY, MD's credentials?
ALINA KHAN-GHANY, MD's NPI is 1053512343 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology